Conquering Diseases

Study Of An Investigational Drug For Adults With A Respiratory Syncytial Virus Infection


Seeking men and women with an Respiratory Syncytial Virus (RSV) Infection and who are at risk of progression to severe illness for a study of an investigational drug


Participants in this study will be randomly selected to receive either the investigational drug or a placebo (looks like the drug but contains no medicine). Participants will need to take the tablets twice a day for up to 5 days. There will be up to 5 study visits over one month

What we're hoping for

We are studying whether an investigational drug is safe and effective in preventing severe illness in adults with a Respiratory Syncytial Virus (RSV) infection.

Additional Information Identifier: NCT06079320

 Principal Investigator

Jennifer  Wang, MD

UMass Memorial Health

 Study Contact

Melissa  Adams



UMMH Memorial Campus

281 Lincoln St. 

Worcester,MA 01605